Table 4.
Characteristics of COVID-19 patients–smoking interaction analysis.
| Interaction | OR (95% CI) | P |
|---|---|---|
| Coexisting disorder | ||
| COPD × Smoking | 1.98 × 10-7 (0, 1.33 × 1049) | .988 |
| Hypertension × Smoking | 0.34 (6.31 × 10-2, 1.11) | .114 |
| Diabetes × | 0.75 (0.22, 2.31) | .615 |
| Cardiovascular disease × Smoking | 2.64 × 10-6 (0, 6.38 × 1034) | .986 |
| Cerebrovascular disease Smoking | 2.93 × 10-4 (0, 1.18 × 1031) | .987 |
| Cancer Smoking | 4.94 × 10-4 (0, 4.26 × 1035) | .986 |
| Chronic renal disease × Smoking | 0.59 (5.22 × 10-14, 6.61 × 1012) | >.99 |
| Tuberculosis Smoking | 7.86 × 10-4 (0, 6.34 × 1029) | .987 |
| Combined | ||
| Number of coexisting disorders × Smoking | 0.58 (0.31, 0.95) | .043 |